Plasma Therapy Market Growth Revenue, Share, Opportunities, Outlook 2033


Posted February 19, 2024 by ravali

Global plasma therapy market size is expected to reach $0.88 Bn by 2028 at a rate of 12.5%, segmented as by type, pure prp, leukocyte-rich prp, pure platelet-rich fibrin (prf), leukocyte-rich fibrin (l-prf)
 
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.

The Plasma Therapy Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Plasma Therapy Market:
https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

According to The Business Research Company’s Plasma Therapy Global Market Report 2024, The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2023 to $0.55 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.The plasma therapy market size is expected to see rapidly grown in the next few years. It will grow to $0.88 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%.

The expansion of cosmetic and aesthetic procedures is expected to drive the growth of the plasma therapy market in the future. Cosmetic and aesthetic procedures encompass medical and surgical methods aimed at improving or restoring an individual's appearance through modifications to physical features. Plasma therapy, particularly in the form of platelet-rich plasma (PRP), is employed in cosmetic and aesthetic procedures to revitalize the skin, stimulate collagen production, and expedite tissue repair. For example, in 2021, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization for board-certified aesthetic plastic surgeons, there were 30.4 million cosmetic/aesthetic procedures performed globally by surgeons, representing a 19.3% increase compared to 2020. Therefore, the surge in cosmetic and aesthetic procedures is propelling the growth of the plasma therapy market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

The plasma therapy market covered in this report is segmented –
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Top Major Players
Takeda Pharmaceutical Company Limited,
Bio Products Laboratory Ltd.,
Arthrex Inc.,
Biotest AG,
China Biologic Products Holdings Inc.

The plasma therapy market report table of contents includes:
1. Executive Summary
2. Plasma Therapy Market Characteristics
3. Plasma Therapy Market Trends And Strategies
4. Plasma Therapy Market - Macro Economic Scenario
5. Global Plasma Therapy Market Size and Growth
6. Plasma Therapy Market Segmentation
7. Plasma Therapy Market Regional And Country Analysis
.....................
33. Key Mergers And Acquisitions In The Plasma Therapy Market
34. Plasma Therapy Market Future Outlook and Potential Analysis
35. Appendix

List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Plasma Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
..................
Table 74: Takeda Pharmaceutical Company Limited Financial Performance
Table 75: Bio Products Laboratory Ltd. Financial Performance
Table 76: Arthrex Inc. Financial Performance
Table 77: Biotest AG Financial Performance
Table 78: China Biologic Products Holdings Inc Financial Performance

Read Related Reports :
https://topprnews.com/interferons-market-size/
https://goodprnews.com/interferons-market-trends/

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By tbrc
Country United Kingdom
Categories Health
Last Updated February 19, 2024